MEI Pharma (MEIP) Rejects Unsolicited $8/sh Proposal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LVS
9. LRCX
10. MRK

Go back to MEI Pharma (MEIP) Rejects Unsolicited $8/sh Proposal

MEI Pharma Board of Directors Rejects Unsolicited Proposal

June 1, 2023 8:00 AM EDT

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (NASDAQ: MEIP) (the Company) today announced that its Board of Directors (the Board) reviewed and rejected the unsolicited and non-binding proposal received on May 23, 2023 from a group represented by Anson Advisors Inc. and Cable Car Capital LLC to acquire all outstanding shares of MEI for not less than $8.00 in cash per share, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of the Companys clinical assets.

The Board, in consultation with the Companys financial and... More